Q2 2021 Holdings
Filed 2021-08-13 | 69 holdings | $52.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $33.5M | 550,000 | 63.4% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $4.8M | 275,000 | 9.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.6M | 20,000 | 5.0% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $2.3M | 200,000 | 4.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.7M | 25,000 | 3.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $1.7M | 50,000 | 3.2% |
| Butterfly Network Inc(BFLY) | COM CL A | 124155102 | $1.4M | 100,000 | 2.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $1.4M | 70,000 | 2.6% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $1.4M | 80,000 | 2.6% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $1.2M | 45,000 | 2.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $475.0K | 75,000 | 0.9% |
| Cvrx Inc(CVRX) | COM | 126638105 | $210.0K | 7,500 | 0.4% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $27.1K | 200,000 | 0.1% |
| ARK ETF TR(ARKG)Put | GENOMIC REV ETF | 00214Q302 | $20.8K | 225,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $14.1K | 246,201 | 0.0% |
| Curevac N VPut | COM | N2451R105 | $11.0K | 150,000 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $10.9K | 838,311 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $9.1K | 900,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $8.9K | 425,000 | 0.0% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $7.9K | 85,000 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $7.6K | 142,418 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $7.5K | 700,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $6.9K | 55,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $6.3K | 140,100 | 0.0% |
| Retrophin Inc | NOTE 2.500% 9/1 | 761299AB2 | $6.0K | $7,000,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $5.3K | 120,000 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $5.2K | 650,000 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $5.1K | 200,000 | 0.0% |
| Alnylam Pharmaceuticals Inc(ALNY)Call | COM | 02043Q107 | $4.2K | 25,000 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $3.5K | 250,000 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $3.1K | 300,000 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS)Call | COM | 462222100 | $3.0K | 75,000 | 0.0% |
| Moderna Inc(MRNA)Call | COM | 60770K107 | $2.9K | 12,500 | 0.0% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $2.9K | 300,000 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $2.8K | 200,000 | 0.0% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $2.6K | 60,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $2.6K | 100,000 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $2.3K | 25,000 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $2.3K | 380,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $2.1K | 80,000 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $2.1K | 650,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $2.1K | 25,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $2.0K | 70,000 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $1.9K | 25,000 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $1.7K | 20,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $1.6K | 10,000 | 0.0% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $1.6K | $2,000,000 | 0.0% |
| Lifesci Acquisition II Corp | COM | 53229E103 | $1.5K | 150,000 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $1.5K | 66,957 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $1.4K | 20,000 | 0.0% |